ALK and inflammatory myofibroblastic tumor: Tumours bearing ALK gene translocations, amplification or activating point mutations, other than ALCL, have been also identified, including non-small cell lung cancer (NSCLC) [5], Inflammatory Myofibroblastic Tumour (IMT) [6] and neuroblastoma [7].